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Abstract
Left ventricular global longitudinal strain (LVGLS) analysis is a sensitive measurement of myocardial deformation most 
often done using speckle-tracking transthoracic echocardiography (TTE). We propose a novel approach to measure LVGLS 
using feature-tracking software on the magnitude dataset of 4D flow cardiovascular magnetic resonance (CMR) and compare 
it to dynamic computed tomography (CT) and speckle tracking TTE derived measurements. In this prospective cohort study 
59 consecutive adult patients with a bicuspid aortic valve (BAV) were included. The study protocol consisted of TTE, CT, 
and CMR on the same day. Image analysis was done using dedicated feature-tracking (4D flow CMR and CT) and speckle-
tracking (TTE) software, on apical 2-, 3-, and 4-chamber long-axis multiplanar reconstructions (4D flow CMR and CT) 
or standard apical 2-, 3-, and 4-chamber acquisitions (TTE). CMR and CT GLS analysis was feasible in all patients. Good 
correlations were observed for GLS measured by CMR (− 21 ± 3%) and CT (− 20 ± 3%) versus TTE (− 20 ± 3%, Pearson’s 
r: 0.67 and 0.65, p < 0.001). CMR also correlated well with CT (Pearson’s r 0.62, p < 0.001). The inter-observer analysis 
showed moderate to good reproducibility of GLS measurement by CMR, CT and TTE (Pearsons’s r: 0.51, 0.77, 0.70 respec-
tively; p < 0.05). Additionally, ejection fraction (EF), end-diastolic and end-systolic volume measurements (EDV and ESV) 
correlated well between all modalities (Pearson’s r > 0.61, p < 0.001). Feature-tracking GLS analysis is feasible using the 
magnitude images acquired with 4D flow CMR. GLS measurement by CMR correlates well with CT and speckle-tracking 
2D TTE. GLS analysis on 4D flow CMR allows for an integrative approach, integrating flow and functional data in a single 
sequence. Not applicable, observational study.
Keywords Echocardiography · Computed tomography · Cardiac magnetic resonance imaging · 4D flow · Global 
longitudinal strain · Bicuspid aortic valve
Abbreviations
LV  Left ventricular
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LVOT  Left ventricular outflow tract
SD  Standard deviation
Introduction
For decades left ventricular (LV) ejection fraction (EF) 
has been the gold standard for quantification of systolic 
LV function [1]. It has been a key metric in therapy and 
prognostication, in particular in patients with valvular heart 
disease. However, more sensitive methods have since been 
in development; [2] of which LV global longitudinal strain 
(GLS) is currently accepted as a more sensitive measure-
ment, that may already be reduced before a decrease in LV 
EF can be observed. Moreover LV GLS allows for quantita-
tive assessment of global and segmental ventricular function 
by measuring myocardial deformation, largely independent 
of angle and ventricular geometry [3–5]. GLS is defined 
as the percentage of shortening between the end-diastolic 
and end-systolic length of the myocardium. This technique 
of deformation measurement has been validated in differ-
ent populations using speckle-tracking echocardiography 
[5–15]. More recently it was shown that GLS can also be 
derived from multiphase Computed Tomography (CT) data-
sets and conventional Cardiovascular Magnetic Resonance 
(CMR) steady state free-precession (SSFP) cine imaging 
using feature-tracking algorithms [16, 17]. However, these 
techniques, especially GLS measurement using CT are still 
new and not yet very well validated. In this study we propose 
a novel method that uses this feature-tracking algorithm on 
magnitude images acquired during 4D flow CMR to quantify 
LV volumes and GLS. 4D flow CMR allows for compre-
hensive post-hoc evaluation of blood flow patterns by 3D 
blood flow visualization and quantification of flow param-
eters [18]. Previous studies have shown that quantification of 
ventricular volume and function can be accomplished with 
4D flow MRI with precision and inter-observer agreement 
comparable to that of SSFP cine imaging [19, 20]. Strain 
analysis would be a valuable additional feature of 4D flow 
CMR, as this would allow for integrative analysis of flow 
and function in one sequence.
The aim of this study was to assess the feasibility of left 
ventricular global longitudinal strain (LVGLS) measure-
ment using magnitude 4D flow Cardiovascular Magnetic 
Resonance (CMR) and dynamic computed tomography 
(CT) datasets, and to provide data on the correlation between 
these novel approaches and the ‘gold standard’ of speckle-
tracking derived GLS values using two-dimensional echo-
cardiography (TTE).
Methods
In this prospective cohort study, adult patients with a 
bicuspid aortic valve (BAV) were included [21–23] The 
study protocol consisted of TTE, CT and CMR on the same 
day. The inclusion criteria were age ≥ 18 year and one of 
the following: [1] aortic stenosis (gradient > 2.5 m/s), [2] 
aortic regurgitation (at least moderate) or [3] ascending 
aortic dilation ≥ 40 mm and/or aortic size index > 2.1 cm/
m2. Patients with contra-indications to CT, CMR or con-
trast agents were excluded. For the current study we only 
included patients who underwent at least two of the three 
imaging modalities. The study complied with the Declara-
tion of Helsinki and was approved by the medical ethical 
committee of the Erasmus Medical Center (MEC14-225). 
Written informed consent was provided by all patients.
Echocardiography
One of two experienced sonographers performed a stand-
ard two-dimensional transthoracic echocardiogram. All 
studies were acquired using harmonic imaging on an 
EPIQ7 ultrasound system (Philips Medical Systems, Best, 
the Netherlands) equipped with an × 5–1 matrix-array 
transducer (composed of 3040 elements with 1–5 MHz). 
A non-foreshortened apical (A) four-chamber (ch), A3ch 
and A2ch were recorded with manual rotation. All echo-
cardiographic images were obtained with a frame rate > 60 
frames per second.
Computed tomography
Acquisition was performed using a dual-source CT 
(Somatom Force or Somatom Definition Flash, Siemens 
Healthcare, Forchheim, Germany). Retrospective ECG-
gated spiral acquisition was applied, and kV was mod-
ulated to patient size and a vascular exam type. Dose 
modulated ECG-pulsing was employed with nominal tube 
current during the 0 to 40% window of the R-R interval, 
and tube current reduced to 20% of the nominal output for 
the remainder to reduce the radiation dose. Reference tube 
current was set at 150 mAs per rotation. The pitch was 
adapted to increase proportionally with higher heart rates. 
No beta blockers were administered prior to the scan. 
Reconstructions were made with a medium smooth kernel. 
In total 20 different reconstructions with a slice thickness 
of 1.5 mm and 1.0 mm overlap were made in each patient 
at every 5% of the R–R interval. The mean dose length 
product (DLP) was 362 mGy-cm (estimated effective dose 
5 mSv, using a conversion factor of k = 0.017). A 65 ml 
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bolus of iodinated contrast material (Iodixanol 320, Visi-
paque, GE Healthcare, Cork, Ireland) was administered 
through an antecubital vein followed by a 40 ml 70/30% 
saline/contrast medium bolus, both at 5 ml/s.
Cardiovascular magnetic resonance imaging
Image acquisition was performed using a 1.5 T clinical MRI 
scanner (Discovery MR450, GE Medical Systems, Milwau-
kee, WI, USA) using a 32-channel phased-array cardiac sur-
face coil. The imaging protocol consisted of black blood 
TSE aorta, 2D phase contrast images for pulse wave velocity 
measurements, SSFP for aortic distensibility measurements, 
contrast enhanced MR angiography and 4D flow CMR of 
the entire heart and aorta. The 4D flow CMR was acquired 
immediately after the bolus injection of 0.1–0.2 mmol/kg 
gadolinium-based contrast agent (Gadovist 1 mmol/ml, 
Bayer, Mijdrecht, The Netherlands). The 4D flow sequence 
has been described before [24]. In short the sequence was 
prescribed in axial plane, including the entire thorax in the 
field of view. The k-space was filled with variable-density 
Poisson-disc under sampling with acceleration factors of 
1.8 × 1.8 (phase × slice) and the parallel imaging algorithm 
used was ESPIRiT. Typical scan parameters were: matrix 
192 × 160 × 78, acquired resolution 2.1 × 1.8 × 2.8  mm, 
reconstructed resolution 2.1 × 1.8 × 1.4  mm, flip angle 
15°, views per segment 4, bandwidth 63 kHz, number of 
reconstructed phases 20 per cardiac cycle, and a velocity 
encoded value set at 250 cm/s. Due to restricted scan time 
per patient no SSFP cine images were acquired.
Image analysis
All images (CMR, CT and TTE) were analyzed by one 
observer (A.T.),who had 6 years of experience in cardiovas-
cular imaging, in a random order and blinded to the results 
of the other image modalities. The TTE, CT, and CMR data 
was then re-measured by a second observer (S.Y.), who has 
one year of experience, blinded to the results of the first 
observer and to the corresponding measurements of the 
other modalities. For 2D TTE, speckle tracking analysis 
was performed using dedicated commercially available 
software (2D Cardiac Performance Analysis, Tomtec Imag-
ing Systems). End-systolic and end-diastolic frames were 
identified manually; additionally the annulus and apex were 
identified manually in end-systole (Fig. 1). Subsequently, 
the software semi-automatically detected the end-diastolic 
and end-systolic myocardial contours. These contours were 
visually checked and corrected if necessary. This process 
was performed in all apical views (A2ch, A3ch, and A4ch).
All CT and CMR images were analyzed semi-automat-
ically using commercially available software from Medis 
Medical Imaging Systems, Leiden The Netherlands. All 
images were loaded into the Medis Suite software (version: 
Fig. 1  Left ventricular parameters by three different modalities in the 
same patient. TTE Transthoracic Echocardiography, CT Computed 
Tomography, CMR Cardiovascular Magnetic Resonance, EDV end-
diastolic volume, ESV end-systolic volume, EF Ejection Fraction, 
GLS Global Longitudinal Strain. Yellow lines depict GLS during the 
cardiac cycle. eS end-systolic phase, eD End-diastolic phase
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3.1.16.6). A2ch, A3ch, and A4ch reconstructions were 
made from the 3D data sets using Medis 3D View (version: 
3.1.18.1). For the CMR analysis only the magnitude images, 
which contain the anatomical data, of the 4D flow data set 
were used. All cardiac phases were included in the multi-
plane reconstructions and endocardial contours were drawn 
manually at both end-diastole and end-systole using Medis 
QMass software (version: 8.1.30.4) where the papillary 
muscles and trabeculations were included in the LV lumen. 
Subsequently GLS, ejection fraction (EF), end-diastolic 
and end-systolic volume (EDV and ESV) were calculated 
using QStrain software (version: 3.1.16.6). Volumes were 
corrected for body surface area (BSA). BSA was calculated 
according to the Dubois formula [25]. In QMass LV con-
tours were drawn manually and focused on adequate track-
ing of the myocardium for precise strain analysis. However, 
changes to the contours necessary for optimal tracking of the 
myocardium caused an underestimation of the ESV. There-
fore, in order to provide data on the inter-modality vari-
ability of the volumes, a second set of separate endocardial 
contours had to be drawn for the measurement EDV, ESV 
and EF. The second trace of endocardial contours, drawn 
for the volumetric analysis, used standard anatomical land-
marks (Supplemental Video 1). However, for adequate strain 
analysis the left ventricular outflow tract (LVOT) had to be 
excluded, and the first trace therefore started more apically 
in both end-systole and end-diastole, (Supplemental Video 
2) to prevent highly positive segmental strain disturbing 
GLS measurement. For the inter-observer variability, twenty 
patients were chosen at random.
Statistical analysis
The IBM SPSS® statistics 21.0 software was used to 
analyze the data. Continuous variables were presented as 
mean ± standard deviation (SD) or as median with an inter-
quartile range. Categorical variables were presented as 
frequencies and percentages. We tested for normality by 
calculating Z-values of skewness and kurtosis, using the 
Shapiro–Wilk test and by visually assessing the data. For 
comparison of normally distributed continuous variables 
between two groups the student’s t-test was used. To quan-
tify correlations the Pearson correlation test was applied. 
Inter-observer agreement between two investigators was 
assessed using Bland–Altman analysis [26]. The bias was 
defined as the mean absolute difference (i.e. the average 
absolute difference between two modalities). The limits of 
agreement between two measurements were determined 
as the mean of the difference ± 1.96 SD. Additionally, the 
coefficient of variation (COV) was provided to compare the 
dispersion of two variables. The COV was defined as the 
SD of the differences of two measurements divided by the 
mean of their means. The statistical tests were two sided and 
a p-value < 0.05 was considered significant.
Results
Fifty-nine patients were included, of whom 37 men 
(63%). Their baseline characteristics are presented in 
Table 1. In 56 patients (95%) echo measurements could 
be performed, two patients did not undergo echocardi-
ography due to organizational reasons and one patient 
was excluded because of insufficient image quality. In 
total 53 patients underwent a CT scan, of which one 
patient was excluded due to technical limitations, there-
fore 52 (88%) patients were included for CT analysis. In 
six patients no CT scan was done due to organizational 
reasons. In 48 patients (83%) 4D flow CMR was per-
formed. In eleven patients 4D flow CMR was missing 
due to organizational reasons (scan time per patient was 
restricted and therefore 4D flow could not always be per-
formed in all patients). The results of all measurements 
Table 1  Baseline characteristics
Data are presented as median [IQR] or n(%)
BMI body-mass index, BSA body surface area, SBP and DBP systolic 
and diastolic blood pressure, Vmax peak aortic valve velocity, AoI aor-
tic valve insufficiency
*Valve type according to Sievers classification
Baseline characteristics Median [IQR] 
(n = 59)
Age, years 34 [19]
Height, cm 180 [23]
Weight, kg 75 [19]
BMI, kg/m2 24 [3]
BSA,  m2 1.9 [0.4]
SBP, mmHg 123 [17]
DBP, mmHg 79 [16]
Aortic valve
Vmax, m/s 2.2 (1.6)
Peak Gradient, mmHg 19 (32)
AoI grade—none 12 (20)
AoI grade—moderate 34 (58)
AoI grade—severe 13 (22)
Sievers type*
Type 0—lat 6 (10)
Type 0—ap 7 (12)
Type 1—LR 23 (49)
Type 1—RN 7 (12)
Type 1—LN 1 (2)
Type 2—LR/RN 7 (12)
Undetermined 2 (2)
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are presented per modality in Table 2. The results of the 
inter-modality agreement are presented in Table 3. All 
CT and MR scans were included. No scans (CT or CMR) 
were excluded because of insufficient image quality. A 
sensitivity analysis was conducted which showed that the 
there was no significant difference when only the patients 
who underwent all three modalities were considered 
(n = 39) (Tables 2 and 3).
Left ventricular global longitudinal strain 
and ejection fraction
When comparing CMR and CT versus TTE, strong correla-
tions (Table 3: Pearson’s r: 0.67, p < 0.001 and Pearson’s r: 
0.65, p < 0.001 respectively) were found for GLS. However, 
especially CMR seemed to slightly overestimate GLS with 
a mean difference − 2% and a bias of 3% when compared 
Table 2  Left ventricular parameters per imaging modality
EDV end-diastolic volume, ESV end-systolic volume, EF ejection fraction, GLS global longitudinal strain, BSA body surface area, TTE transtho-
racic echocardiography, CT computed tomography, CMR cardiovascular magnetic resonance
*In this analysis all patients that completed 2 or more imaging modalities were considered
a In this sensitivity analysis data is shown when only patients are considered that completed all three imaging modalities Data are presented as 
mean ± standard deviation
All patients* All three modalities  completeda
CT (n = 52) CMR (n = 48) TTE (n = 56) CT (n = 39) CMR (n = 39) TTE (n = 39)
GLS (%) − 20 ± 3 − 21 ± 3 − 20 ± 3 − 21 ± 2 − 21 ± 3 − 20 ± 3
EF (%) 58 ± 6 54 ± 7 55 ± 6 58 ± 5 55 ± 7 55 ± 5
EDV (ml) 192 ± 65 203 ± 62 185 ± 64 183 ± 58 193 ± 62 180 ± 57
EDV/BSA (ml/m2) 99 ± 26 105 ± 26 95 ± 26 95 ± 24 100 ± 24 94 ± 24
ESV (ml) 82 ± 33 94 ± 34 83 ± 33 77 ± 28 87 ± 32 81 ± 29
ESV/BSA (ml/m2) 42 ± 13 48 ± 15 42 ± 15 40 ± 12 45 ± 13 42 ± 12
Table 3  Inter-modality agreement
LOA limit of agreement, EDV end-diastolic volume, ESV end-systolic volume, EF ejection fraction, GLS global longitudinal strain, TTE tran-
sthoracic echocardiography, CT computed tomography, CMR cardiovascular magnetic resonance
a all significant with a p < 0.001
b Defined as the mean absolute difference
All Patients All three modalities
Pearson’s  ra Biasb Mean difference Lower LOA Upper LOA Pearson’s  ra Biasb Mean difference Lower LOA Upper 
LOA
CMR vs. TTE (n = 45) CMR vs. TTE (n = 39)
GLS (%) 0.67 3 − 2 − 7 3 0.69 2 − 2 − 6 3
EF (%) 0.61 4 0 − 11 10 0.62 4 0 − 10 11
EDV (ml) 0.84 31 16 − 53 85 0.86 28 13 − 50 75
ESV (ml) 0.82 17 8 − 32 47 0.85 15 6 − 28 40
CT vs. TTE (n = 49) CT vs. TTE (n = 39)
GLS (%) 0.65 2 − 1 − 5 4 0.65 2 − 1 − 5 3
EF (%) 0.67 4 2 − 6 11 0.69 4 3 − 5 11
EDV (ml) 0.85 26 8 − 61 77 0.88 23 3 − 54 59
ESV (ml) 0.83 13 0 − 36 36 0.87 12 − 4 − 33 25
CT vs. CMR (n = 42) CT vs. CMR (n = 39)
GLS (%) 0.62 2 1 − 4 6 0.56 2 1 − 5 6
EF (%) 0.68 5 3 − 8 14 0.56 5 3 − 8 14
EDV (ml) 0.93 19 − 11 − 56 35 0.93 18 − 10 − 54 33
ESV (ml) 0.90 14 − 11 − 40 19 0.90 13 − 10 − 38 18
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Fig. 2  Inter-modality agreement for global longitudinal strain. Agree-
ment between TTE Transthoracic Echocardiography, CT Computed 
Tomography, CMR Cardiovascular Magnetic Resonance, GLS global 
longitudinal strain. Bland–Altman plots and identity line (black) for 
CT versus TTE (blue) and CMR versus TTE (green) and CT versus 
CMR (red). Dashed red lines indicate ± 1.96 SD. COV coefficient of 
variation
Fig. 3  Inter-modality agreement for ejection fraction. Agreement 
between TTE Transthoracic Echocardiography, CT Computed 
Tomography, CMR Cardiovascular Magnetic Resonance, EF ejection 
fraction. Bland–Altman plots and identity line (black) for CT versus 
TTE (blue) and CMR versus TTE (green) and CT versus CMR (red). 
Dashed red lines indicate ± 1.96 SD. COV coefficient of variation
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to TTE (Fig. 2). The results of the EF measurements per 
modality are presented in Table 2; results for the agreement 
analysis of EF are shown in Table 3 and Fig. 3. Of all three 
modalities EF, measurement by CT yielded the highest mean 
EF: 58 ± 6%, where CMR yielded the lowest mean EF of the 
three modalities (54 ± 7%).
Volume measurement
Correlations for LV end-diastolic volumes (Supplemental 
Fig. 4) were strong for both CMR and CT compared to TTE 
(Table 3, Pearson’s r: 0.84 and 0.85, both p < 0.001 respec-
tively), where the mean difference was smallest between 
CT and TTE. As shown in Table 2, EDV measurements 
were larger on CMR (203 ± 62 ml) compared with TTE 
(185 ± 64 ml), which resulted in the largest bias of 31 ml 
and limits of agreement ranging between − 53 ml and 85 ml.
Correlations for ESV were comparable to those found 
for EDV (Supplemental Fig. 5). ESV measured by CMR 
and CT correlated strongly with TTE (Pearson’s r: 0.82 and 
0.83 respectively, both p < 0.001). Here too CT compared 
best with TTE with a mean difference of − 0.3 ml (bias: 
13 ml) versus 7.8 ml on average for CMR compared with 
TTE (bias: 17 ml).
Inter‑observer variability
Inter-observer variability was assessed for all three modali-
ties; the results of the second observer agreement analysis 
for TTE are presented in Supplemental Fig. 6. Both for GLS 
and EF good inter-observer agreement was found (Pearson’s 
r: 0.70, p < 0.001 and 0.60, p = 0.006 respectively), and also 
for EDV and ESV (Pearson’s r: 0.96 and 0.90, p < 0.001 
respectively). The relatively large mean difference for EF 
(− 9.4%) for TTE, was mainly driven by observer 1 over-
estimating both EDV (mean difference: 13.7 ml) and ESV, 
with a tendency towards a more significant overestimation 
of the ESV (mean difference: 27.2 ml) relative to the EDV. 
Inter-observer variability for CT is presented in Supplemen-
tal Fig. 7, where a strong correlation between observers was 
found for GLS with a mean difference of − 1.8% on average. 
Finally, inter-observer variability for CMR is presented in 
Supplemental Fig. 8, where a moderate correlation for GLS 
(Pearson’s r: 0.51, p = 0.023) was found.
Discussion
In this prospective cohort study we demonstrated for the first 
time that the assessment of GLS is feasible using a feature-
tracking algorithm on the magnitude images acquired by 4D 
flow CMR directly after gadolinium contrast. This opens the 
way for an integrative one-sequence approach in which both 
flow and functional information can be acquired simulta-
neously. Moreover, in this study functional LV parameters 
measured by CMR correlated well with 2D TTE, with a 
mean difference comparable to that found in other studies 
using ‘conventional’ SSFP cine CMR images [27–30]. On 
average GLS in our cohort of BAV patients was similar to 
that found using SSPF CMR images in a healthy adult popu-
lation [31].
Although LV functional analysis by CT has been pos-
sible for a number of years there is limited data available 
on the value of CT in GLS assessment [16, 32–34]. CT has 
been shown to correlate closely with CMR and TTE for left 
ventricular assessment, [28] and more recently also for GLS 
analysis [29]. Additionally, studies have described good cor-
relations between CT and TTE [16, 33]. Our study confirms 
these correlations with TTE and CMR for both GLS and EF. 
Furthermore, CT had the best reproducibility of all three 
modalities, reflected in the lowest coefficient of variation in 
the second-observer analysis. The observed overestimation 
of EF by CT compared to CMR could be explained by the 
fact that, especially on the long axis A3ch-view, papillary 
muscles are often difficult to discern resulting in a smaller 
ESV and subsequent high EF. Furthermore, unlike TTE and 
CMR, CT has the disadvantage of significant radiation expo-
sure for the patient, since imaging of the complete cardiac 
cycle is necessary for GLS analysis.
CT and CMR correlated well both for GLS and EF. 
Based on the high spatial resolution CT could have been 
expected to outperform CMR, as CMR may require more 
observer interpretation in determining the endocardial con-
tour. Indeed we observed a lower coefficient of variation 
for CT versus TTE (COV: 10.7) compared to CMR versus 
TTE (COV: 12.0) for both GLS and for EF (COV: 7.5 vs 
9.8). Additionally, second observer analysis for CT showed 
a lower COV for all LV measurements.
A clear limitation of this study is the need for separate 
contours for the GLS and volumes, caused by the frequent 
inadequate tracking of the basal and mid and anterior septal 
segments by the feature-tracking algorithm on CT and CMR 
(Supplemental Fig. 9). Tracing the endocardial contour in 
the apical three chamber view from the mitral valve to the 
aortic valve orifice (Supplemental Video 1) often resulted 
in positive strain values in these segments, lowering the 
GLS. This could be resolved by placing the endocardial 
marker more apically (Supplemental Video 2) resulting 
in an underestimation of the EDV and ESV. A third video 
shows the same process for MR in apical three and 4 cham-
ber views (Supplemental Videos 3 and 4 respectively). The 
difficulty here is that when abandoning the anatomical land-
mark there is no clear alternative, which introduces possible 
inter-observer variability. Although more time consuming 
we chose to draw a second endocardial tracing focusing on 
the volume quantification when this problem occurred. With 
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regard to the post-processing process, we found the TTE 
workflow to be significantly less time intensive compared 
to CT and CMR, partly because with TTE the sonographer 
directly acquired the apical 2-, 3-, and 4-chamber views. 
Both with CT and CMR the observer had to create these 
views retrospectively. This may allow for more precise 
reconstruction and analysis, but it is also more time intensive 
as it increases workflow complexity, and creates a possible 
source of bias between observers. It has been shown that 
both observer experience and the software used for analysis 
can have a significant influence on the agreement for CMR 
(30, 31) as for TTE (32). And although outside the scope of 
this study we agree that user experience is an important fac-
tor in LV functional analysis. This is perhaps best reflected 
in the second observer analysis for TTE, where a small but 
consistent difference in EDV and ESV resulted in a system-
atically lower EF for the second observer. Another limitation 
is that we did not have SSFP CMR cine images available for 
these patients, which would have allowed to also compare 
4D flow CMR with the ‘gold standard’ for volume quantifi-
cation and feature-tracking strain analyses on SSFP images. 
We feel that part of the variation between CMR and the 
other modalities could be explained by the inferior spatial 
resolution of the magnitude image datasets. Furthermore, 
the standard deviation of GLS and EF in this patient cohort 
is small, as all patients had relatively preserved LV function. 
A future study could evaluate how this technique performs 
in patients with a reduced LV function.
Conclusion
Feature-tracking GLS analysis is feasible using the magni-
tude images acquired by 4D flow CMR with adequate imag-
ing quality. GLS measurement by CMR correlates well with 
CT and speckle-tracking 2D TTE. GLS analysis on 4D flow 
CMR allows for an integrative approach in which flow and 
functional data can be acquired in one sequence. Future stud-
ies should aim to validate these findings in a healthy control 
population, preferably compared with SSPF cine imaging.
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